Scilex Holding (SCLX) Debt to Equity (2021 - 2026)

Scilex Holding (SCLX) recorded quarterly Debt to Equity of -$0.32 in Q1 2026, up 37.52% quarter-over-quarter from -$0.51 in Q4 2025, and down 70.48% on a YoY basis from -$1.08 in Q1 2025.

Scilex Holding (SCLX) Debt to Equity (2021 - 2026) Analysis & Trends

Scilex Holding's Debt to Equity history runs 6 years deep, the most recent figure standing at -$0.32 for Q1 2026.

  • In Q1 2026, Debt to Equity fell 70.48% year-over-year to -$0.32; the TTM figure through Mar 2026 stood at -$0.32 (down 70.48% YoY), while the FY2025 annual figure was -$0.51, down 174.45% from the prior year.
  • Debt to Equity was -$0.32 for Q1 2026 at Scilex Holding, up from -$0.51 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.53 in Q2 2023 to a low of -$0.75 in Q3 2023.
  • Historically, Debt to Equity has averaged -$0.22 across 5 years, with a median of -$0.29 in 2025.
  • Biggest YoY gain for Debt to Equity was 19358.71% in 2023; the steepest drop was 5696.78% in 2023.
  • A 5-year view of Debt to Equity shows it stood at -$0.01 in 2022, then plunged by 5500.45% to -$0.73 in 2023, then surged by 74.44% to -$0.19 in 2024, then sank by 174.45% to -$0.51 in 2025, then surged by 37.52% to -$0.32 in 2026.
  • The last three Debt to Equity figures came in at -$0.32 (Q1 2026), -$0.51 (Q4 2025), and -$0.26 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn -
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 1.39
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 0.68
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn -9.70
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 1.07
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 6.24
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 0.94
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 0.72
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 2.22
10 Scilex Holding 48.31 Mn -101.62 Mn 4.15 Mn -0.32

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.32
Dec 31, 2025 -0.51
Sep 30, 2025 -0.26
Jun 30, 2025 -0.16
Mar 31, 2025 -0.19
Dec 31, 2024 -0.19
Sep 30, 2024 -0.47
Jun 30, 2024 -0.49
Mar 31, 2024 -0.58
Dec 31, 2023 -0.73
Sep 30, 2023 -0.75
Jun 30, 2023 1.53
Sep 30, 2022 -0.01
Jun 30, 2022 -0.01
Dec 31, 2021 -0.49